Listing & Compliance Notices

Aclarion, Inc. received a nasdaq compliance regained notice regarding late filing (rules 5250(c)(1), 12B-25).

“received a notice from Nasdaq notifying the Company that because the Company remained delinquent in filing its Form 10-Q, the Company no longer complied with Nasdaq Listing Rule 5250(c)(1), which requires companies with securities listed on Nasdaq to timely file all required periodic reports with the SEC. The Company filed the Form 10-Q on August 25, 2023. On August 28, 2023, Nasdaq confirmed that the Company had regained compliance with Rule 5250(c)(1) and that this matter is now closed.”

ABVC BIOPHARMA, INC. received a nasdaq compliance regained notice regarding stockholders equity.

“July 31, 2023, the Company issued 300,000 shares of its common stock, par value $0.001 per share (“Common Stock”) and 200,000 pre-funded warrants, at an exercise price of $0.01 per share, in a registered direct offering. Pursuant to this transaction, the stockholders’ equity was increased by $1.75M. We also previously disclosed that on August 1, 2023, the holder of $500,000 of Notes (as hereinafter defined) converted such notes at $3.50 per share and received 142,857 shares of Common Stock. As a result of this conversion, the stockholders’ equity was increased by $0.5M. Additionally, as previ”

ACTELIS NETWORKS INC received a nasdaq noncompliance notice notice regarding stockholders equity (rules 5550(b)(1)).

“August 25, 2023, Actelis Networks, Inc. (the "Company") received a notification letter (the "Notice") from The Nasdaq Stock Market LLC (the "Nasdaq") indicating that the Company was not in compliance with Nasdaq's Listing Rule 5550(b)(1) because the Company's shareholders' equity for the quarter ended June 30, 2023 (the "Quarter"), as reported in the Company's Form 10-Q for the Quarter, was below the minimum shareholders' equity requirement of $2,500,000 (the "Shareholders' Equity Requirement"). The Notice had no immediate effect on the Company's continued listing on Nasdaq, subject to the Com”

MOBIX LABS, INC received a nasdaq deficiency notice notice regarding other (rules 5550(a)(3)).

“August 24, 2023, Chavant Capital Acquisition Corp. (the “Company”) received a written notice (the “Notice”) from the Listing Qualifications staff (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”), notifying the Company that it currently does not satisfy Listing Rule 5550(a)(3), which requires the Company to have at least 300 “Public Holders” (as defined in Listing Rule 5005(a)(36)) for continued listing on the Nasdaq Capital Market (the “Minimum Public Holders Rule”). The Notice followed the Company’s communication to the Staff that it was not in compliance with Listing Rule 5550(a)(3)”

Global System Dynamics, Inc. received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).

“August 23, 2023, Global System Dynamics, Inc. (the “Company”) received a deficiency letter from the Listing Qualifications Department (the “Staff”) of the Nasdaq Stock Market (“Nasdaq”) notifying the Company that the Company no longer complies with Nasdaq Listing Rule 5250(c)(1) as a result of the Company’s delay in filing its Form 10-Q for the quarter ended June 30, 2023. The letter was issued by Nasdaq under Nasdaq Listing Rule 5810(c)(2) for the Company’s failure to comply with Nasdaq Listing Rule 5250(c)(1). The Company has 60 calendar days, or until October 22, 2023, to submit to Nasdaq a”

Clean Energy Special Situations Corp. received a nasdaq noncompliance notice notice regarding late filing.

“not in compliance with Nasdaq’s continued listing standards because the Company did not timely file its Quarterly Report on Form 10-Q for the quarter ended June 30, 2023 (the “ Quarterly Report ”). Under Nasdaq rules, the Company now has 60 calendar days (or until October 23, 2023) to submit a plan to regain compliance. If Nasdaq accepts the Company’s plan, Nasdaq can grant an exception of up to 180 calendar days from the Quarterly Report’s original due date, which 180 day period would end on February 12, 2024, to regain compliance. The Company can regain compliance with Nasdaq’s continued lis”

iPower Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

“ule 5550(a)(2) (the “Minimum Bid Price Requirement”). Pursuant to Nasdaq Listing Rule 5810(c)(3)(A), the Company has an”

Crown Electrokinetics Corp. received a nasdaq noncompliance notice notice regarding audit committee (rules 5605(c)(2)).

“August 24, 2023, Crown Electrokinetics Corp. (the “Company”) received notice (the “Audit Committee Notice”) from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) stating that the Company did not comply with Nasdaq’s audit committee composition requirement under Nasdaq Listing Rule 5605(c)(2) (the “Audit Committee Rule”) following the departure of directors in December 2022. The Audit Committee Rule requires that the Audit Committee of the Company’s Board of Directors (the “Board”) be composed of at least three members, each of whom must meet indepen”

Z Squared Inc. received a nasdaq deficiency notice notice regarding market value (rules 5550(b)(2), 5810(c)(3)(C)).

“August 28, 2023, the Company received a letter (the “Nasdaq Staff Deficiency Letter”) from The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, for the last thirty-three consecutive business days, the Market Value of Listed Securities, as defined by Nasdaq (“MVLS”) had been below the $35 million minimum requirement for continued listing on The Nasdaq Capital Market under Nasdaq Listing Rule 5550(b)(2). In accordance with Nasdaq Listing Rule 5810(c)(3)(C), the Company has been provided an initial period of 180 calendar days, or until February 26, 2024, to regain compliance. The letter states”

Monopar Therapeutics received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

“August 28, 2023, Monopar Therapeutics Inc. (the “Company”) received a letter (the “Notice”) from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, for the previous 30 consecutive business days, the bid price for the Company’s common stock had closed below the minimum $1.00 per share requirement for continued listing on The Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2) (the “Bid Price Requirement”). The Notice has no effect at this time on the Company’s common stock, which continues to trade on The Nasdaq Capit”

AUDDIA INC. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).

“satisfy Listing Rule 5550(b)(1). In its quarterly report on Form 10-Q for the period ended June 30, 2023 filed on August 24, 2023, the Company reported stockholders’ equity of $4,331,778. On August 25, 2023, Nasdaq confirmed that the Company had regained compliance with Rule 5550(b)(1) and that this matter is now closed.”

AUDDIA INC. received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).

“August 23, 2023, the Company received a notice from Nasdaq notifying the Company that because the Company remained delinquent in filing its Form 10-Q, the Company no longer complied with Nasdaq Listing Rule 5250(c)(1), which requires companies with securities listed on Nasdaq to timely file all required periodic reports with the SEC. The Company filed the Form 10-Q on August 24, 2023. On August 25, 2023, Nasdaq confirmed that the Company had regained compliance with Rule 5250(c)(1) and that this matter is now closed. Resolution of Nasdaq Notice Regarding Stockholders’ Equity Requirement As pre”

ALKALINE WATER Co INC received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).

“August 23, 2023, The Alkaline Water Company Inc. (the "Company") received a deficiency letter (the "Letter") from the Listing Qualifications Department of The Nasdaq Stock Market (the "Nasdaq"). The Letter notified the Company that since the Company had not yet filed its Form 10-Q for the period ended June 30, 2023 (the "Form 10-Q"), and because the Company did not timely file its Form 10-K for the fiscal year ended March 31, 2023 (the "Initial Delinquent Filing"), the Company does not comply with the Nasdaq's Listing Rule 5250(c)(1) (the "Rule") relating to the Company's obligation to file pe”

HeartSciences Inc. received a nasdaq noncompliance notice notice regarding minimum bid price (rules 5550(a)(2)).

“August 1, 2023, the Staff notified the Company that the bid price of its common stock failed to close above the minimum $1 requirement for the past 30 trading days, pursuant to Nasdaq Listing Rule 5550(a)(2) (the “Bid Price Rule”). The Company attended an August 17, 2023, hearing before the Panel and requested the continued listing of its securities on the Nasdaq Capital Market pending its return to compliance with the Equity Rule and the Bid Price Rule. On August 28, 2023, the Company received a decision from the Panel granting the Company’s request for continued listing on the Nasdaq Capital”

HeartSciences Inc. received a nasdaq hearing update notice regarding stockholders equity (rules 5250(b)(1)).

“August 28, 2023, the Company received a decision from the Panel granting the Company’s request for continued listing on the Nasdaq Capital Market, subject to the Company demonstrating compliance with the Equity Rule on or before November 21, 2023, and certain other conditions. In addition, The Company has until January 29, 2024, to demonstrate compliance with the minimum $1 bid price requirement pursuant to the Bid Price Rule. Statements contained herein relating to the Company or its management’s intentions, hopes, beliefs, expectations or predictions of the future, including, but not limited”

Orbital Infrastructure Group, Inc. received a nasdaq delisting notice notice regarding other (rules 5101, 5110(b), IM-5101-1).

“August 24, 2023, the Company received written notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, in accordance with Nasdaq Listing Rules 5101, 5110(b) and IM-5101-1, the Chapter 11 Cases served as an additional basis for delisting of the Company’s securities. The Company does not intend to appeal this determination. Trading of the Company’s common stock will be suspended at the opening of business on September 5, 2023, and Nasdaq will file a Form 25-NSE with the Securities and Exchange Commission (the “SEC”), which will remov”

RiceBran Technologies received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).

“equity be at least $2,500,000 (the “Stockholders’ Equity Requirement”). As reported in its Form 10-Q, the Company’s shareholders’ equity as of June 30, 2023 was approximately $882,000, and, as of August 24, 2023, the Company did not meet the alternative compliance standards of market value of listed securities or net income from continuing operations. The Notice”

Tingo Group, Inc. received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).

“August 22, 2023, Tingo Group, Inc. (the “Company”) received a notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1) (the “Rule”) due to a delay in filing its Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2023 (the “Form 10-Q”) with the Securities and Exchange Commission (the “SEC”). The Rule requires listed companies to timely file all required periodic financial reports with the SEC. The Notice is only a notification of deficiency, n”

Gardiner Healthcare Acquisitions Corp. received a nasdaq noncompliance notice notice regarding late filing (rules 5250(c)(1)).

“August 18, 2023, the Company received a late filer notification letter (the “ Letter ”) from the Listing Qualifications department of The Nasdaq Stock Market LLC (“ Nasdaq ”) notifying the Company that due to the delay in filing the Form 10-Q, the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1), which requires listed companies to timely file all periodic financial reports with the SEC. The Letter has no immediate effect on the listing or trading of the Company’s common stock on the Nasdaq Global Market. As stated in the Letter, in accordance with Nasdaq rules, the Company has”

C5 Acquisition Corp received a nyse deficiency notice notice regarding late filing (rules 802.01E).

“August 23, 2023, C5 Acquisition Corporation (the “Company”) received a late filer notification letter (the “Letter”) from the New York Stock Exchange (the “NYSE”) notifying that the Company is not in compliance with Section 802.01E of the NYSE Listed Company Manual as a result of its failure to timely file its Quarterly Report on Form 10-Q for the quarter ended June 30, 2023 (the “Form 10-Q”) with the Securities and Exchange Commission (the “SEC”). The NYSE notified the Company that, under NYSE rules, the Company will have six months from August 21, 2023 to file the Form 10-Q with the SEC. The”

African Gold Acquisition Corp received a nyse delisting notice notice regarding late filing (rules 802.01E).

“the Company’s inability to file its Quarterly Reports on Form 10-Q for the periods ended June 30, 2022, September 30, 2022, March 31, 2023 and June 30, 2023 and Annual Report on Form 10-K for the fiscal year ended December 31, 2022 by August 22, 2023, which is the maximum time allowed under Section 802.01E of the NYSE’s Listed Company Manual. The Company does not intend to appeal the NYSE’s determination. The foregoing actions and their consequences could affect the liquidity and value of the Company’s securities. The Units and the Ordinary Shares may be traded on the over-the-counter markets”

Iris Acquisition Corp received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).

“August 23, 2023, Iris Acquisition Corp (the “Company”) received a written notice (the “Late 10-Q Notice”) from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”), notifying the Company that as a result of the Company not timely filing its Quarterly Report on Form 10-Q for the quarter ended June 30, 2023 (the “Late 10-Q”), the Company failed to comply with the periodic filing requirements for continued listing set forth in Rule 5250(c)(1) of the Nasdaq Listing Rules. The Company, by filing this Form 8-K, discloses its receipt of the Late 10-Q Notice in”

ConvexityShares Trust received a nyse deficiency notice notice regarding market value.

“August 25, 2023, Teucrium Trading LLC (“Teucrium”), sponsor of ConvexityShares Trust (the “Trust”) and its series, ConvexityShares Daily 1.5x SPIKES Futures ETF and ConvexityShares 1x SPIKES Futures ETF (each a “Fund” and together, the “Funds”), received a notice (the “Notice”) from NYSE Regulation indicating that each Fund was found to be non-compliant with the continued listing requirements for Trust Issued Receipts listed on NYSE Arca Inc. (the “Exchange”). Specifically, NYSE Regulation found the Funds to be out of compliance with Rule 8.200-E(d)(2)(C), which requires each Fund to have an a”

Keenova Therapeutics plc received a nyse_american delisting notice notice regarding other (rules 1003(c)(iii)).

“August 28, 2023, Mallinckrodt plc (the “Company”) was notified by the staff of NYSE Regulation that NYSE Regulation has determined to commence proceedings to delist the ordinary shares, par value $0.01 per share, of the Company from the NYSE American LLC (“NYSE American”) and that trading in the Company’s ordinary shares will be suspended immediately. NYSE Regulation advised that it has determined that the Company is no longer suitable for listing and will commence delisting proceedings pursuant to Section 1003(c)(iii) of the NYSE American Company Guide in light of the Company’s disclosure on”

Staffing 360 Solutions, Inc. received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).

“August 23, 2023, Staffing 360 Solutions, Inc. (the “Company”) received a notice (the “Notice”) from the Listing Qualifications Staff (the “Staff”) of the Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that as it has not yet filed its Quarterly Report on Form 10-Q (the “Form 10-Q”) for the period ended June 30, 2023, the Company now no longer complies with Listing Rule 5250(c)(1) for continued listing on Nasdaq. Previously, the Staff had granted the Company an exception until October 16, 2023 to file its delinquent Form 10-Q for the period ended April 1, 2023 (the “Initial Delinquent”

SIFCO INDUSTRIES INC received a nyse_american noncompliance notice notice regarding late filing (rules 1007).

“August 22, 2023, SIFCO Industries, Inc. (the “Company” or “SIFCO”) received a notice from the NYSE American LLC (the “NYSE American”) indicating that, due to the delay in the filing of its Quarterly Report on Form 10-Q for the period ended June 30, 2023 (the “Form 10-Q”) (as reported on the Form 12b-25 filed by the Company on August 14, 2023), the Company is not in compliance with the continued listing standards of the NYSE American and is subject to the procedures and requirements set forth in Section 1007 of the NYSE American Company Guide. The Company expects to complete the preparation, re”

PHP Ventures Acquisition Corp. received a nasdaq deficiency notice notice regarding other (rules 5550(a)(3)).

“August 24, 2023, PHP Ventures Acquisition Corp., a Delaware corporation (the “ Company ”), received a written notice from the Listing Qualifications Department of The Nasdaq Stock Market (“ Nasdaq ”) indicating that the Company was not in compliance with Listing Rule 5550(a)(3) (the “ Minimum Public Holders Rule ”), which requires the Company to have at least 300 public holders for continued listing on the Nasdaq Capital Market. The Notice is only a notification of deficiency, not of imminent delisting, and has no current effect on the listing or trading of the Company’s securities on Nasdaq C”

Applied UV, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

“ule 5550(a)(2) (the “Bid Price Rule”). Pursuant to Nasdaq Listing Rule 5810(c)(3)(A), the Company was provided an initial”

Interactive Strength, Inc. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5450(b)(1)(A)).

“equity be at least $10.0 million (the “Stockholders’ Equity Requirement”). As reported in the Form 10-Q, the Company’s stockholders’ equity as of June 30, 2023 was approximately $5.0 million. In accordance with Nasdaq Listing Rules, the Company has 45 calendar days from the date of the Notice, or until October 6, 2023, to submit a plan to regain compliance with the”

Onconetix, Inc. received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).

“August 22, 2023, Blue Water Biotech, Inc. (the “ Company ”) received a deficiency notice (the “ Notice ”) from the Nasdaq Stock Market LLC (“ Nasdaq ”) that the Company was not in compliance with Nasdaq’s continued listing standards (the “ Listing Rules ”) as set forth in Listing Rule 5250(c)(1) given the Company’s failure to timely file its quarterly report on Form 10-Q for the quarter ended June 30, 2023 (the “ 10-Q ”). Consistent with the Listing Rules, the Company has 60 calendar days from the date of the Notice to provide Nasdaq with a specific plan to achieve and sustain compliance with”

Kubient, Inc. received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).

“August 15, 2023, Kubient, Inc. (the “Company”) filed a Notification of Late Filing on Form 12b-25, indicating, among other things, that the filing of its Quarterly Report on Form 10-Q for the quarter ended June 30, 2023 (the “Form 10-Q”) would be delayed principally due to the Company’s auditor having not completed their review of the Form 10-Q for the period ended June 30, 2023. Because of the delayed filing of the Form 10-Q with the United States Securities and Exchange Commission (the “SEC”), the Company received a letter from the Listing Qualifications Staff of The Nasdaq Stock Market L”

SenesTech, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

“August 25, 2023, we received a letter from the listing qualifications staff (the “Staff”) of The Nasdaq Stock Market (“Nasdaq”) providing notification that the bid price for our common stock had closed below $1.00 per share for the previous 30 consecutive business days and our common stock no longer meets the minimum bid price requirement for continued listing under Nasdaq Listing Rule 5550(a)(2). In accordance with Nasdaq Listing Rule 5810(c)(3)(A), we have an initial period of 180 calendar days, or until February 21, 2024, to regain compliance. To regain compliance, the closing bid price of”

Four Leaf Acquisition Corp received a nasdaq noncompliance notice notice regarding late filing (rules 5250(c)(1)).

“August 22, 2023, from the Nasdaq Listing Qualifications Department (“Nasdaq”) indicating that the Company remains in non-compliance with the timely filing requirement for continued listing under Nasdaq Listing Rule 5250(c)(1), which requires listed companies to timely file all required periodic reports with the Securities and Exchange Commission. The Notice will have no immediate effect on the listing or trading of the Company’s common stock, although there can be no assurances that further delays in the filing of the Form 10-Q will not have an impact on the listing or trading of the Company’s”

Solidion Technology Inc. received a nasdaq deficiency notice notice regarding market value (rules 5450(b)(2)(A), 5810(c)(3)(C)).

“August 21, 2023, Nubia received a letter (the “ MVLS Notice ”) from the Listing Qualifications Department (the “ Staff ”) of The Nasdaq Stock Market LLC (“ Nasdaq ”) notifying Nubia that for the last 30 consecutive business days prior to the date of the MVLS Notice, the Company’s Minimum Market Value of Listed Securities (“ MVLS ”) was less than $50.0 million, which does not meet the requirement for continued listing on The Nasdaq Global Market, as required by Nasdaq Listing Rule 5450(b)(2)(A) (the “ MVLS Rule ”). In accordance with Nasdaq Listing Rule 5810(c)(3)(C), the Staff has provided Nu”

Cyngn Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

“August 24, 2023, Cyngn Inc. (the “Company”) received a notification letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, because the closing bid price for the Company’s common stock listed on Nasdaq was below $1.00 for 30 consecutive trading days, the Company no longer meets the minimum bid price requirement for continued listing on The Nasdaq Capital Market under Nasdaq Marketplace Rule 5550(a)(2), requiring a minimum bid price of $1.00 per share (the “Minimum Bid Price Requirement”). The notification has no immediate effect o”

Fortune Rise Acquisition Corp received a nasdaq deficiency notice notice regarding market value (rules 5450(b)(2)(A), 5810(c)(3)(C)).

“August 21, 2023, the Company received a written notice (the “Notice”) from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, for the last 30 consecutive business days, the Company’s Market Value of Listed Securities (“MVLS”) was below the minimum of $50 million required for continued listing on The Nasdaq Global Market pursuant to Nasdaq Listing Rule 5450(b)(2)(A) (the “Market Value Standard”). The Staff also noted that the Company does not meet the requirements under Nasdaq Listing Rule 5450(b)(3)(A) (Total Assets/Total R”

Magnum Opus Acquisition Ltd received a nyse deficiency notice notice regarding late filing (rules 802.01E).

“August 22, 2023, Magnum Opus Acquisition Limited (the “Company”) received a notice (the “Notice”) from the NYSE Regulation staff of the New York Stock Exchange (the “NYSE”) stating that the Company is not in compliance with Section 802.01E of the NYSE Listed Company Manual (the “NYSE Rules”) because it has not timely filed its Quarterly Report on Form 10-Q for the quarter ended June 30, 2023 (the “June 2023 Form 10-Q”) with the Securities Exchange Commission (the “SEC”). The Notice states that under the NYSE Rules, the Company has six months from the due date of the June 2023 Form 10-Q, or unt”

Airspan Networks Holdings Inc. received a nyse_american deficiency notice notice regarding minimum bid price (rules 1003(f)(v)).

“July 10, 2023 from NYSE American stating that it is not in compliance with the continued listing standard set forth in Section 1003(f)(v) of the Company Guide because the Company’s common stock was selling for a substantial period of time at a low price per share, which NYSE American determined to be a 30-trading day average of less than $0.20 per share. The Notice stated that the Company’s continued listing is predicated on it effecting a reverse stock split of its common stock or otherwise demonstrating sustained price improvement within a reasonable period of time, which NYSE American has d”

Airspan Networks Holdings Inc. received a nyse_american extension granted notice regarding stockholders equity (rules 1003(a)(i), 1003(a)(ii)).

“August 23, 2023, the Company received a letter from NYSE American stating that NYSE American reviewed and accepted the Plan, providing an extension for compliance with Sections 1003(a)(i) and (ii) of the NYSE American Company Guide until December 9, 2024. The NYSE American staff will review the Company periodically for compliance with the initiatives outlined in the Plan. If the Company is not in compliance with the continued listing standards by December 9, 2024, or if the Company does not make progress consistent with the Plan during the Plan period, the NYSE American staff will initiate del”

BONK, INC. received a nasdaq compliance regained notice regarding minimum bid price (rules 5550(a)(2)).

“August 24, 2023, the closing bid price of the Company’s common stock has been at $1.00 per share or greater. As a result, the Company has regained compliance with the Rule and the Staff has indicated that the matter is now closed.”

Catheter Precision, Inc. received a nyse_american deficiency notice notice regarding late filing (rules 1007).

“August 22, 2023, the Company received a notice from NYSE Regulation stating that the Company is not in compliance with the continued listing standards of the NYSE American under the timely filing criteria set forth in Section 1007 of the NYSE American Company Guide. The non-compliance results from the Company’s failure to timely file its Quarterly Report on Form 10-Q for the quarter ended June 30, 2023 by the extended filing due date of August 21, 2023. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.”

Aclarion, Inc. received a nasdaq noncompliance notice notice regarding late filing (rules 5250(c)(1)).

“August 23, 2023, the Company received a notice from Nasdaq notifying the Company that because the Company remains delinquent in filing its Form 10-Q, the Company no longer complies with Nasdaq Listing Rule 5250(c)(1), which requires companies with securities listed on Nasdaq to timely file all required periodic reports with the SEC. The notice received from Nasdaq has no immediate effect on the listing or trading of the Company’s securities on Nasdaq. However, if the Company would fail to timely regain compliance with Rule 5250(c)(1), the Company’s securities would be subject to delisting from”

JOINT Corp received a nasdaq noncompliance notice notice regarding late filing (rules 5250(c)(1)).

“August 22, 2023, The Joint Corp. (the “Company”) received a notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market, LLC (“Nasdaq”) advising the Company that it was not in compliance with Nasdaq’s continued listing requirements under the Nasdaq Listing Rule 5250(c)(1) (the “Rule”) as a result of the Company’s failure to file its Quarterly Report on Form 10-Q for the quarter ended June 30, 2023 (the “Form 10-Q”) with the United States Securities and Exchange Commission (the “SEC”) in a timely manner, which deadline was August 21, 2023 (as a result of the Comp”

GridAI Technologies Corp. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

“August 24, 2023, First Wave BioPharma, Inc. (the “Company”) received a letter from the Listing Qualifications Staff of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, based upon the closing bid price of the Company’s common stock, par value $0.0001 per share (“Common Stock”), for the last 30 consecutive business days, the Company is not currently in compliance with the requirement to maintain a minimum bid price of $1.00 per share for continued listing on The Nasdaq Capital Market, as set forth in Nasdaq Listing Rule 5550(a)(2) (the “Notice”). The Notice has no immediate effect on the”

RenovoRx, Inc. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).

“August 21, 2023, RenovoRx, Inc. (the “Company”) received a letter (the “Letter”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, as of August 18, 2023, the Company was not in compliance with the minimum stockholders’ equity requirement for continued listing on The Nasdaq Capital Market, under Listing Rule 5550(b)(1), because the Company’s stockholders’ equity of $1,188,000 as reported in the Company’s Quarterly Report on Form 10-Q for the period ended June 30, 2023 was below the required minimum of $2.5 million, and because, as of June 30”

AUDDIA INC. received a nasdaq noncompliance notice notice regarding late filing (rules 5250(c)(1)).

“August 23, 2023, the Company received a notice from Nasdaq notifying the Company that because the Company remains delinquent in filing its Form 10-Q, the Company no longer complies with Nasdaq Listing Rule 5250(c)(1), which requires companies with securities listed on Nasdaq to timely file all required periodic reports with the SEC. The notice received from Nasdaq has no immediate effect on the listing or trading of the Company’s securities on Nasdaq. However, if the Company would fail to timely regain compliance with Rule 5250(c)(1), the Company’s securities would be subject to delisting from”

Charge Enterprises, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1)).

“August 22, 2023, Charge Enterprises, Inc. (sometimes referred to herein as “ Company ”, “ we ,” “ us ,” “ our ” or similar terms) received a notice from The Nasdaq Stock Market (“ Nasdaq ”) that the closing bid price for our common stock had been below $1.00 per share for the previous 30 consecutive business days, and that we are therefore not in compliance with the minimum bid price requirement for continued inclusion on The Nasdaq Global Market under Nasdaq Listing Rule 5450(a)(1) (“ Rule 5450(a)(1) ”). Nasdaq’s notice has no immediate effect on the listing or trading of our common stock on”

Nova Vision Acquisition Corp received a nasdaq deficiency notice notice regarding other (rules 5550(a)(3)).

“August 18, 2023, Nova Vision Acquisition Corp. (“Company”) received a written notice (the “Notice”) from the Nasdaq Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) indicating that the Company was not in compliance with Listing Rule 5550(a)(3) (the “Minimum Public Holders Rule”), which requires the Company to have at least 300 public holders for continued listing on the Nasdaq Capital Market (the “Minimum Public Holders Rule”). The Notice is only a notification of deficiency, not of imminent delisting, and has no current effect on the listing or trading of the Company’s”

MOBIX LABS, INC received a nasdaq deficiency notice notice regarding shareholders (rules 5550(a)(3)).

“August 18, 2023, in response to an inquiry by the staff (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”), Chavant Capital Acquisition Corp. (the “Company”) notified the Staff that it currently does not satisfy Listing Rule 5550(a)(3), which requires that the Company have at least 300 “Public Holders” (as defined in Listing Rule 5005(a)(36)) for continued listing on the Nasdaq Capital Market (the “Minimum Public Holders Rule”). The Company is monitoring the number of its Public Holders and will consider options available to it to potentially achieve compliance. Such notification will not”

Trump Media & Technology Group Corp. received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).

“August 24, 2023 Digital World Acquisition Corp. (the “ Company ”) announced that it received an expected letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“ Nasdaq ”) stating that the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1) (the “ Rule ”) because it has not yet filed its Quarterly Report on Form 10-Q for the period ended June 30, 2023 (the “ Second Quarter Form 10-Q ”) with the Securities and Exchange Commission (the “ SEC ”). The Rule requires listed companies to timely file all required periodic financial reports with the SEC. As previ”